Patents Assigned to BETA THERAPEUTICS PTY LTD
  • Heparanase inhibitors and use thereof
    Patent number: 11787783
    Abstract: The invention relates to functionalized dihydro- and tetrahydro-quinazoline compounds, pharmaceutical compositions comprising such compounds, and the use of such compounds as heparanase inhibitors for the treatment of diseases or conditions related to heparanase.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: October 17, 2023
    Assignee: Beta Therapeutics Pty Ltd
    Inventors: Keats Nelms, Brett Schwartz, Colin Jackson, Martin Banwell, Edward Hammond
  • Heparanase inhibitors and use thereof
    Patent number: 11718609
    Abstract: The invention relates to functionalized quinazoline compounds, pharmaceutical compositions comprising such compounds, and the use of such compounds as heparanase inhibitors for the treatment of diseases or conditions related to heparanse activity.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: August 8, 2023
    Assignee: BETA THERAPEUTICS PTY LTD
    Inventors: Keats Nelms, Brett Schwartz, Colin Jackson, Martin Banwell, Edward Hammond